Active Ingredient(s): Procarbazine
FDA Approved: * July 22, 1969
Pharm Company: * SIGMA TAU
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Matulane Overview

Procarbazine is a chemotherapy medication used for the treatment of Hodgkin's lymphoma and brain cancers.[1] For Hodgkin's it is often used together with chlormethine, vincristine, and prednisone while for brain cancers such as glioblastoma multiforme it is used with lomustine and vincristine.[1] It is typically taken by mouth.[1] Common side effect include low blood cell counts and vomiting.[1] Other side effects include tiredne...

Read more Matulane Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Matulane Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Matulane: (2 results)

Sorted by National Drug Code
  • 54482-053 Matulane 50 mg Oral Capsule by Sigma-tau Pharmaceuticals, Inc.
  • 54482-054 Matulane 50 mg Oral Capsule by Leadiant Biosciences, Inc.

Other drugs which contain Procarbazine or a similar ingredient: (1 result)